Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Piotr Rutkowski

Showing results (111-120 of 491) with videos related to

Pageof 50
Sort By:
Radiation Oncology (London, England)|November 28, 2025
Hypofractionated radiotherapy with hyperthermia in radiation-associated and in-volume recurrent soft tissue sarcomas of the extremities and trunk wall: results of a proof-of-concept prospective trialKonrad Zasadziński, Aneta Borkowska, Dorota Kopeć, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|April 13, 2026
Desmoid Tumors-Biology-Driven Management and Treatment SelectionDyda Dao, Katarzyna Kozak, Anne Mailhot, et al.
International Journal of Cancer|January 10, 2008
Rectal gastrointestinal stromal tumors associated with a novel germline KIT mutationAgnieszka Woźniak, Piotr Rutkowski, Raf Sciot, et al.
Polski Przeglad Chirurgiczny|September 16, 2014
The outcome of targeted therapy in advanced gastrointestinal stromal tumors (GIST) with non-exon 11 KIT mutationsCzesław Osuch, Piotr Rutkowski, Karolina Brzuszkiewicz, et al.
Polish Journal of Pathology : Official Journal of the Polish Society of Pathologists|August 13, 2009
Her2, EGFR and TOPIIA gene amplification and protein expression in synovial sarcoma before and after combined treatmentKonrad Ptaszyński, Anna Szumera-Ciećkiewicz, Klara Zakrzewska, et al.
Current Oncology Reports|March 28, 2025
Neoadjuvant or Adjuvant Chemotherapy in Soft-Tissue Sarcoma?Piotr Remiszewski, Kinga Filipek, Agata Pisklak, et al.
Biomedicines|March 28, 2024
Molecular and Clinicopathological Biomarkers in the Neoadjuvant Treatment of Patients with Advanced Resectable MelanomaPiotr J Błoński, Anna M Czarnecka, Krzysztof Ostaszewski, et al.
International Journal of Molecular Sciences|March 28, 2024
MicroRNAs as Prognostic Biomarkers and Therapeutic Targets in ChondrosarcomaPalina Skipar, Mritunjoy Dey, Jakub Piątkowski, et al.
The American Journal of Surgical Pathology|October 15, 2011
Succinate dehydrogenase-deficient GISTs: a clinicopathologic, immunohistochemical, and molecular genetic study of 66 gastric GISTs with predilection to young ageMarkku Miettinen, Zeng-Feng Wang, Maarit Sarlomo-Rikala, et al.
Cancers|July 30, 2020
Neoadjuvant Treatment Options in Soft Tissue SarcomasMateusz Jacek Spałek, Katarzyna Kozak, Anna Małgorzata Czarnecka, et al.
Pageof 50

Showing results (111-120 of 491) with videos related to

Sort By:
Pageof 50
Radiation Oncology (London, England)|November 28, 2025
Hypofractionated radiotherapy with hyperthermia in radiation-associated and in-volume recurrent soft tissue sarcomas of the extremities and trunk wall: results of a proof-of-concept prospective trialKonrad Zasadziński, Aneta Borkowska, Dorota Kopeć, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|April 13, 2026
Desmoid Tumors-Biology-Driven Management and Treatment SelectionDyda Dao, Katarzyna Kozak, Anne Mailhot, et al.
International Journal of Cancer|January 10, 2008
Rectal gastrointestinal stromal tumors associated with a novel germline KIT mutationAgnieszka Woźniak, Piotr Rutkowski, Raf Sciot, et al.
Polski Przeglad Chirurgiczny|September 16, 2014
The outcome of targeted therapy in advanced gastrointestinal stromal tumors (GIST) with non-exon 11 KIT mutationsCzesław Osuch, Piotr Rutkowski, Karolina Brzuszkiewicz, et al.
Polish Journal of Pathology : Official Journal of the Polish Society of Pathologists|August 13, 2009
Her2, EGFR and TOPIIA gene amplification and protein expression in synovial sarcoma before and after combined treatmentKonrad Ptaszyński, Anna Szumera-Ciećkiewicz, Klara Zakrzewska, et al.
Current Oncology Reports|March 28, 2025
Neoadjuvant or Adjuvant Chemotherapy in Soft-Tissue Sarcoma?Piotr Remiszewski, Kinga Filipek, Agata Pisklak, et al.
Biomedicines|March 28, 2024
Molecular and Clinicopathological Biomarkers in the Neoadjuvant Treatment of Patients with Advanced Resectable MelanomaPiotr J Błoński, Anna M Czarnecka, Krzysztof Ostaszewski, et al.
International Journal of Molecular Sciences|March 28, 2024
MicroRNAs as Prognostic Biomarkers and Therapeutic Targets in ChondrosarcomaPalina Skipar, Mritunjoy Dey, Jakub Piątkowski, et al.
The American Journal of Surgical Pathology|October 15, 2011
Succinate dehydrogenase-deficient GISTs: a clinicopathologic, immunohistochemical, and molecular genetic study of 66 gastric GISTs with predilection to young ageMarkku Miettinen, Zeng-Feng Wang, Maarit Sarlomo-Rikala, et al.
Cancers|July 30, 2020
Neoadjuvant Treatment Options in Soft Tissue SarcomasMateusz Jacek Spałek, Katarzyna Kozak, Anna Małgorzata Czarnecka, et al.
Pageof 50